Sumati Gupta, MD, is a tenured Associate Professor in the Division of Oncology, Department of Medicine, at University of Utah‘s Huntsman Cancer Institute (HCI). Dr. Gupta specializes in the treatment ...
Please provide your email address to receive an email when new articles are posted on . Elizabeth Plimack, MD, MS, chief of the division of genitourinary medical oncology at Fox Chase Cancer Center, ...
Dr. Joshua K. Sabari sat down with Dr. Daniel V. Araujo to discuss topline takeaways from the 2025 ASCO Meeting across the realm of genitourinary oncology Dr. Joshua K. Sabari sat down with Dr. Daniel ...
The Case Comprehensive Cancer Center extends congratulations to Shilpa Gupta, MD on her appointment to director of genitourinary medical oncology at Taussig Cancer Institute and co-leader of the ...
Pathologic re-review of NMIBC surgical specimens by genitourinary pathologists led to a change in risk stratification in one-fifth of cases. Pathologic re-review of transurethral resection of bladder ...
CHICAGO--(BUSINESS WIRE)--Dr. Lauren Streicher, a leading gynecologist and menopause expert, addresses the widespread issue of genitourinary syndrome of menopause (GSM) in her latest podcast episode.
Vaginal estrogen, vaginal DHEA, oral ospemifene, vaginal moisturizers may be beneficial for some genitourinary symptoms. (HealthDay News) — Vaginal estrogen, vaginal dehydroepiandrosterone (DHEA), ...
National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced changes in leadership across multiple ...
A systematic literature review was performed on March 2023 using PubMed, MEDLINE, and Embase databases according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement.
Dr. Guru Sonpavde, Medical Director of Genitourinary Oncology (GU), AdventHealth Cancer Institute joins the podcast to dive deep into some of the clinical research that AdventHealth is pioneering and ...
Sarcopenia as a marker to assess the surveillance necessity after a 5-year cancer-free period in patients who undergo radical cystectomy: A multi-institutional retrospective study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results